博士研究生導師簡介
姓名 | 洪浩 | 研究方向: |
| ||
聯系方式 | haohong@nju.edu.cn | ||||
學術兼職: 美國核醫學與分子影像學會(SNMMI)會員 歐洲核醫學學會(EANM)會員 | |||||
個人簡介 | |||||
工作簡曆: 2019.9~目前:教授,伟德官网手机版 2014.9~2019.8:助理教授,密歇根大學放射學系 2013.7~2014.8:助理研究員,威斯康星大學麥迪遜分校放射學系 2008.7~2013.6:博士後研究員,威斯康星大學麥迪遜分校放射學系 科研情況簡介: 教授、博士生導師。2008年在南京大學生命科學學院獲得博士學位,曾在美國威斯康星大學麥迪遜分校進行博士後研究,2014年在密歇根大學擔任獨立PI。主要研究方向是新型醫學分子影像試劑的研究,尤其是可用于正電子斷層掃描(PET)成像試劑的設計,同時專注于應用新型生物醫學材料作為多模态影像試劑以及疾病診療一體化試劑,以及研究材料-機體相互作用的生物學機理。獲美國核醫學與分子影像學會的Berson-Yalow獎(2012&2016)等分子影像學重要獎項。在Nature Nanotechnology, JACS, ACS Nano等雜志上發表100多篇SCI研究論文。 研究方向簡介:
| |||||
代表性論文[近5年通訊作者和第一作者] | |||||
1. Chen D, Zhou Y, Yang D, Guan M, Zhen M, Lu W, Van Dort ME, Ross BD, Wang C, Shu C, Hong H. Positron Emission Tomography/Magnetic Resonance Imaging of Glioblastoma Using a Functionalized Gadofullerene Nanoparticle. ACS Appl Mater Interfaces. 2019 Jun 19;11(24):21343-21352. 2. Yang J, Lu W, Xiao J, Zong Q, Xu H, Yin Y, Hong H, Xu W. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications. Acta Biomater. 2018 Oct 1;79:306-316. 3. Yang D, Yao X, Dong J, Wang N, Du Y, Sun S, Gao L, Zhong Y, Qian C, Hong H. Design and Investigation of Core/Shell GQDs/hMSN Nanoparticles as an Enhanced Drug Delivery Platform in Triple-Negative Breast Cancer. Bioconjug Chem. 2018 Aug 15;29(8):2776-2785. 4. Chen D, Zhang G, Li R, Guan M, Wang X, Zou T, Zhang Y, Wang C, Shu C, Hong H, Wan LJ. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release. J Am Chem Soc. 2018 Jun 20;140(24):7373-7376. 5. Peng Y, Yang D, Lu W, Hu X, Hong H, Cai T. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance. Acta Biomater. 2017 Oct 1;61:193-203. 6. Chen D, Yang D, Dougherty CA, Lu W, Wu H, He X, Cai T, Van Dort ME, Ross BD, Hong H. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials. ACS Nano. 2017 Apr 25;11(4):4315-4327. 7. Yang D, Comeau A, Bowen WD, Mach RH, Ross BD, Hong H, Van Dort ME. Design and Investigation of a [ 18 F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging. Mol Pharm. 2017 Mar 6;14(3):770-780. 8. Yang D, Feng L, Dougherty CA, Luker KE, Chen D, Cauble MA, Banaszak Holl MM, Luker GD, Ross BD, Liu Z, Hong H. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Biomaterials. 2016 Oct;104:361-71. 9. Chen F*, Hong H*(共同第一作者), Goel S, Graves SA, Orbay H, Ehlerding EB, Shi S, Theuer CP, Nickles RJ, Cai W. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine. ACS Nano. 2015;9(4):3926-34. 10. Hong H, Wang F, Zhang Y, Graves SA, Eddine SB, Yang Y, Theuer CP, Nickles RJ, Wang X, Cai W. Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting. ACS Appl Mater Interfaces. 2015 Feb 11;7(5):3373-81. 11. Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Mol Pharm. 2015 Feb 2;12(2):403-10. | |||||
承擔科研項目[項目負責人] | |||||
| |||||
獲獎情況 | |||||
|